RESUMEN
Mitogen- and antigen-induced interferon-gamma (IFN-gamma) responses of peripheral blood leucocytes from cervids were evaluated by a commercial whole-blood assay. The assay was applied to Mycobacterium bovis-infected white-tailed deer and reindeer, M bovis BCG-vaccinated white-tailed deer and elk, and unvaccinated, uninfected white-tailed deer, fallow deer, elk and reindeer. The responses of the M bovis-infected white-tailed deer to pokeweed mitogen (PWM) varied with time and between individuals. The responses of the M bovis-infected reindeer to PWM and M bovis purified protein derivative (PPD) were positively associated. Samples from tuberculosis-free captive herds in various parts of the USA were also evaluated. Four per cent of fallow deer, 20 per cent of elk, 44 per cent of white-tailed deer, and 91 per cent of reindeer had responses to PWM exceeding 0.25 Delta optical density, that is, PWM stimulation minus no stimulation. The specificity of the responses to M bovis PPD and a Mycobacterium tuberculosis complex-specific antigen rESAT-6:CFP-10, excluding animals not responding to PWM, ranged from 78 per cent to 100 per cent and was dependent upon the species and the positive response cut-off value. The results show that the commercial assay is valid for the detection of TB in reindeer; however, further development of the assay will be required before it is used in surveillance programmes for white-tailed deer, fallow deer, and elk.
Asunto(s)
Antígenos Bacterianos/inmunología , Vacuna BCG/inmunología , Ciervos , Interferón gamma/biosíntesis , Mycobacterium bovis/inmunología , Tuberculosis/veterinaria , Animales , Concanavalina A/farmacología , Ciervos/inmunología , Ciervos/microbiología , Femenino , Leucocitos , Activación de Linfocitos , Masculino , Fitohemaglutininas/farmacología , Mitógenos de Phytolacca americana/farmacología , Reno/inmunología , Reno/microbiología , Tuberculosis/sangre , Tuberculosis/diagnóstico , Tuberculosis/inmunología , Vacunación/veterinariaRESUMEN
In July 1995, an outbreak of acute febrile illness affected 11 (48%) of 23 family members from Nebraska and Kansas who had vacationed at a Colorado cabin in June. Similar symptoms were identified among five (17%) of 30 additional persons from Nebraska, Kansas, Florida, and Texas who had vacationed at the same cabin. Symptoms suggested tick-borne relapsing fever (TBRF). Although no spirochetes were detected in available blood smears from five case-patients, Borrelia hermsii was cultured from the blood of one case-patient and two chipmunks trapped near the cabin. Case-patients were more likely than non-ill cabin visitors to have slept on the floor (odds ratio [OR] = 28.0, 95% confidence interval [CI] = 3.0-258) or in the top bunk bed (OR = 5.2, 95% CI = 1.1-25.1). Tick-borne relapsing fever should considered in the differential diagnosis of fever in patients who have stayed overnight in mountain cabins in the western United States.
Asunto(s)
Brotes de Enfermedades , Fiebre Recurrente/epidemiología , Adolescente , Adulto , Anciano , Animales , Bacteriemia/microbiología , Borrelia/aislamiento & purificación , Estudios de Casos y Controles , Niño , Preescolar , Colorado/epidemiología , Femenino , Florida , Vivienda , Humanos , Técnicas para Inmunoenzimas , Kansas , Masculino , Persona de Mediana Edad , Nebraska , Factores de Riesgo , Roedores , Texas , Garrapatas , ViajeRESUMEN
An assessment of the risk of illness associated with Escherichia coli O157:H7 in ground beef was drafted in 2001. The exposure assessment considers farm, slaughter, and preparation factors that influence the likelihood of humans consuming ground beef servings containing E. coli O157:H7 and the number of cells in a contaminated serving. Apparent seasonal differences in prevalence of cattle infected with E. coli O157:H7 corresponded to seasonal differences in human exposure. The model predicts that on average 0.018% of servings consumed during June through September and 0.007% of servings consumed during the remainder of the year are contaminated with one or more E. coli O157:H7 cells. This exposure risk is combined with the probability of illness given exposure (i.e., dose response) to estimate a U.S. population risk of illness of nearly one illness in each 1 million (9.6 x 10(-7)) servings of ground beef consumed. Uncertainty about this risk ranges from about 0.33 illness in every 1 million ground beef servings at the 5th percentile to about two illnesses in every 1 million ground beef servings at the 95th percentile.
Asunto(s)
Seguridad de Productos para el Consumidor , Escherichia coli O157/crecimiento & desarrollo , Contaminación de Alimentos/análisis , Productos de la Carne/microbiología , Modelos Teóricos , Animales , Bovinos , Enfermedades de los Bovinos/epidemiología , Infecciones por Escherichia coli/epidemiología , Infecciones por Escherichia coli/veterinaria , Contaminación de Alimentos/prevención & control , Manipulación de Alimentos/métodos , Microbiología de Alimentos , Humanos , Prevalencia , Salud Pública , Medición de Riesgo , Estaciones del AñoRESUMEN
Yersinia pestis infection was diagnosed in 3 dogs. Clinical signs included lethargy (3 dogs), pyrexia (2 dogs), and a purulent skin lesion in the cervical region (2 dogs). Yersinia pestis infection is a potentially fatal zoonotic disease of human beings. Human cases have resulted from contact with infected domestic cats; however, the risk of human infection from contact with infected domestic dogs is unknown. Dogs frequently are exposed to Y pestis in areas in which there are plague epizootics; however, clinical illness in dogs is rare. In the western United States, where Yersinia pestis is endemic, plague should be considered in the differential diagnosis when examining dogs with nonspecific fever and lethargy.
Asunto(s)
Enfermedades de los Perros/diagnóstico , Peste/veterinaria , Yersinia pestis/aislamiento & purificación , Animales , Anticuerpos Antibacterianos/sangre , Diagnóstico Diferencial , Enfermedades de los Perros/microbiología , Perros , Femenino , Masculino , Peste/diagnóstico , Peste/microbiología , Yersinia pestis/inmunología , ZoonosisRESUMEN
Existing strategies for long-term bovine tuberculosis (bTB) control/eradication campaigns are being reconsidered in many countries because of the development of new testing technologies, increased global trade, continued struggle with wildlife reservoirs of bTB, redistribution of international trading partners/agreements, and emerging financial and animal welfare constraints on herd depopulation. Changes under consideration or newly implemented include additional control measures to limit risks with imported animals, enhanced programs to mitigate wildlife reservoir risks, re-evaluation of options to manage bTB-affected herds/regions, modernization of regulatory framework(s) to re-focus control efforts, and consideration of emerging testing technologies (i.e. improved or new tests) for use in bTB control/eradication programs. Traditional slaughter surveillance and test/removal strategies will likely be augmented by incorporation of new technologies and more targeted control efforts. The present review provides an overview of current and emerging bTB testing strategies/tools and a vision for incorporation of emerging technologies into the current control/eradication programs.
Asunto(s)
Tuberculosis Bovina/diagnóstico , Animales , Anticuerpos Antibacterianos/sangre , Bovinos , Interferón gamma/sangre , Sensibilidad y Especificidad , Prueba de Tuberculina/veterinaria , Tuberculosis Bovina/epidemiología , Tuberculosis Bovina/prevención & controlRESUMEN
To determine the cost effectiveness of vaccinating against Lyme disease, we used a decision tree to examine the impact on society of six key components. The main measure of outcome was the cost per case averted. Assuming a 0.80 probability of diagnosing and treating early Lyme disease, a 0.005 probability of contracting Lyme disease, and a vaccination cost of $50 per year, the mean cost of vaccination per case averted was $4,466. When we increased the probability of contracting Lyme disease to 0.03 and the cost of vaccination to $100 per year, the mean net savings per case averted was $3,377. Since few communities have average annual incidences of Lyme disease >0. 005, economic benefits will be greatest when vaccination is used on the basis of individual risk, specifically, in persons whose probability of contracting Lyme disease is >0.01.
Asunto(s)
Antígenos de Superficie/economía , Proteínas de la Membrana Bacteriana Externa/economía , Vacunas Bacterianas/economía , Grupo Borrelia Burgdorferi/inmunología , Lipoproteínas , Enfermedad de Lyme/prevención & control , Vacunación/economía , Antígenos de Superficie/administración & dosificación , Proteínas de la Membrana Bacteriana Externa/administración & dosificación , Vacunas Bacterianas/administración & dosificación , Análisis Costo-Beneficio , Árboles de Decisión , Humanos , Enfermedad de Lyme/economía , Probabilidad , Estados UnidosRESUMEN
PROBLEM/CONDITION: Lyme disease is caused by infection with the spirochete Borrelia burgdorferi and is the most commonly reported vector-borne disease in the United States. Borrelia burgdorferi is transmitted to humans by infected Ixodes scapularis and I. pacificus ticks. Lyme disease is typically evidenced in its early stage by a characteristic rash (erythema migrans), accompanied by nonspecific symptoms (e.g., fever, malaise, fatigue, headache, myalgia, and arthralgia). Lyme disease can usually be treated successfully with standard antibiotic regimens. REPORTING PERIOD: 1992-1998. DESCRIPTION OF SYSTEM: Lyme disease surveillance data are reported to CDC through the National Electronic Telecommunication System for Surveillance, a computerized public health database for nationally notifiable diseases. During 1992-1998, data regarding reported cases of Lyme disease included county and state of residence, age, sex, and date of onset. Descriptive analyses were performed, and cumulative incidence by state, county, age group, and sex were calculated. RESULTS: During 1992-1998, a total of 88,967 cases of Lyme disease was reported to CDC by 49 states and the District of Columbia, with the number of cases increasing from 9,896 in 1992 to 16,802 in 1998. A total of 92% of cases was reported from eight northeastern and mid-Atlantic states and two north-central states. Children aged 5-9 years and adults aged 45-54 years had the highest mean annual incidence. INTERPRETATION: Lyme disease is a highly focal disease, with the majority of reported cases occurring in the northeastern and north-central United States. The number of reported cases of Lyme disease increased during 1992-1998. Geographic and seasonal patterns of disease correlate with the distribution and feeding habits of the vector ticks, I. scapularis and I. pacificus. PUBLIC HEALTH ACTION: The results presented in this report will help clinicians evaluate the prior probability of Lyme disease and provide the framework for targeting human Lyme disease vaccine use and other prevention and treatment interventions.
Asunto(s)
Enfermedad de Lyme/epidemiología , Vigilancia de la Población , Humanos , Estados Unidos/epidemiologíaRESUMEN
Reported cases of Lyme disease in Hunterdon County, New Jersey, increased almost 200% from 75 (67/100,000 population) in 1992 to 216 (193/100,000 population) in 1993. For evaluation of risk factors for Lyme disease and for determination of the cause of this increase, a case-control study was conducted, and the reporting practices of physicians' offices were evaluated. For cases reported in 1993, age and sex distribution, month of disease onset, and proportion of cases with erythema migrans rash were within expected limits. Analysis of age-matched case-control data showed that rural residence; clearing periresidential brush during spring and summer months; and the presence of rock walls, woods, deer, or a bird feeder on residential property were associated with incident Lyme disease. A review of physician reporting patterns suggested that the increase in reported cases in 1993 was due to improved reporting as well as to an increase in the numbers of patients diagnosed with Lyme disease. In addition, substantial underreporting of Lyme disease by physicians' offices was found.
Asunto(s)
Notificación de Enfermedades , Enfermedad de Lyme/epidemiología , Pautas de la Práctica en Medicina , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Humanos , Incidencia , Lactante , Masculino , Persona de Mediana Edad , New Jersey/epidemiología , Estudios Prospectivos , Análisis de Regresión , Factores de Riesgo , Encuestas y CuestionariosRESUMEN
Exposure to cats infected with Yersinia pestis is a recently recognized risk for human plague in the US. Twenty-three cases of cat-associated human plague (5 of which were fatal) occurred in 8 western states from 1977 through 1998, which represent 7.7% of the total 297 cases reported in that period. Bites, scratches, or other contact with infectious materials while handling infected cats resulted in 17 cases of bubonic plague, 1 case of primary septicemic plague, and 5 cases of primary pneumonic plague. The 5 fatal cases were associated with misdiagnosis or delays in seeking treatment, which resulted in overwhelming infection and various manifestations of the systemic inflammatory response syndrome. Unlike infections acquired by flea bites, the occurrence of cat-associated human plague did not increase significantly during summer months. Plague epizootics in rodents also were observed less frequently at exposure sites for cases of cat-associated human plague than at exposure sites for other cases. The risk of cat-associated human plague is likely to increase as residential development continues in areas where plague foci exist in the western US. Enhanced awareness is needed for prompt diagnosis and treatment.